United States — Food and Drug Administration & Pomerantz LLP
8 shared events · Importance 4 · Last updated Jul 05, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to JK Industries for significant violations of Current Good Manufacturing Practice regulations, which triggered the investigation and stock price drop.
Pomerantz LLP: Pomerantz LLP is investigating claims on behalf of investors of JK Industries regarding potential securities fraud and unlawful business practices.
Jun 16, 2026 · 6 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs related to Zoetis' Bedinvetmab, contributing to its weakening adoption.
Pomerantz LLP: Pomerantz LLP is the law firm that filed the class action lawsuit against Zoetis, representing investors who suffered losses. This event enhances the firm's reputation in corporate and securities litigation.
May 18, 2026 · 251 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration's delayed clearance for Caris Life Sciences' TriNav Advance product is a key factor contributing to the company's financial issues and the subsequent investor investigations.
Pomerantz LLP: Pomerantz LLP is investigating claims on behalf of investors of Caris Life Sciences for potential securities fraud and other unlawful business practices.
Jun 02, 2026 · 31 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body that Oculis will not pursue a filing with for its drug candidate OCS-01, following the failed clinical trials.
Pomerantz LLP: Pomerantz LLP is investigating Oculis for potential securities fraud and unlawful business practices on behalf of investors. This firm is actively seeking investors to join a class action lawsuit.
May 29, 2026 · 43 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Pomerantz LLP interact across events, view sentiment trends, and discover connected entities.
Open Dashboard